Stone Ridge Asset Management LLC acquired a new position in shares of Halyard Health Inc (NYSE:HYH) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 7,249 shares of the medical instruments supplier’s stock, valued at approximately $335,000.
A number of other institutional investors also recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its position in Halyard Health by 5.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 3,292,483 shares of the medical instruments supplier’s stock worth $148,262,000 after purchasing an additional 159,434 shares in the last quarter. Bank of New York Mellon Corp increased its position in Halyard Health by 4.0% during the 4th quarter. Bank of New York Mellon Corp now owns 918,798 shares of the medical instruments supplier’s stock worth $42,429,000 after purchasing an additional 35,688 shares in the last quarter. Copper Rock Capital Partners LLC increased its position in Halyard Health by 3.6% during the 4th quarter. Copper Rock Capital Partners LLC now owns 677,184 shares of the medical instruments supplier’s stock worth $31,631,000 after purchasing an additional 23,469 shares in the last quarter. Channing Capital Management LLC purchased a new stake in Halyard Health during the 4th quarter worth about $26,411,000. Finally, Wells Fargo & Company MN increased its position in Halyard Health by 2.0% during the 4th quarter. Wells Fargo & Company MN now owns 525,136 shares of the medical instruments supplier’s stock worth $24,251,000 after purchasing an additional 10,360 shares in the last quarter. Hedge funds and other institutional investors own 91.32% of the company’s stock.
HYH opened at $46.08 on Monday. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.98 and a quick ratio of 2.74. The stock has a market capitalization of $2,162.08, a price-to-earnings ratio of 19.86, a price-to-earnings-growth ratio of 5.39 and a beta of 1.62. Halyard Health Inc has a 12 month low of $35.24 and a 12 month high of $50.99.
A number of research firms recently commented on HYH. Zacks Investment Research cut Halyard Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 6th. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Finally, TheStreet upgraded Halyard Health from a “c+” rating to a “b” rating in a report on Monday, December 4th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Halyard Health currently has an average rating of “Buy” and an average price target of $49.33.
WARNING: This report was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.wkrb13.com/2018/04/02/7249-shares-in-halyard-health-inc-hyh-purchased-by-stone-ridge-asset-management-llc.html.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.